ADVFN - Advanced Financial Network.
HOME» NASDAQ » A » AMGN Stock Price » AMGN Stock News

Amgen Inc. Share News

 Amgen Inc. (mm) Stock Price
AMGN Stock Price
 Amgen Inc. (mm) Stock Chart
AMGN Stock Chart
 Amgen Inc. (mm) Stock News
AMGN Stock News
 Amgen Inc. (mm) Company Information
AMGN Company Information
 Amgen Inc. (mm) Stock Trades
AMGN Stock Trades

Bayer To Develop Cancer Treatment With Amgen

FRANKFURT -(Dow Jones)- German chemical and pharmaceutical company Bayer AG (BAYN.XE) said Tuesday it has agreed with Amgen Inc. (AMGN) to develop and commercialize a new antibody for treating cancer. MAIN FACTS: -Financial details of the deal weren't disclosed. -Bayer will collaborate with Amgen at its Munich site from the research phase to the completion of initial clinical trials. -After the initial trials have been completed, Bayer will be responsible for further development and commercialization of the product candidate. -In 2009, Bayer had entered into an agreement with Micromet, Inc. to produce another antibody. -Micromet was acquired by Amgen in early 2012. -Frankfurt Bureau, Dow Jones Newswires; 49-69-29725-500

Stock News for Amgen Inc. (AMGN)
DateTimeHeadline
08/25/201609:45:00U.S. Hot Stocks: Hot Stocks to Watch
08/24/201620:10:00FDA Rejects Amgen Hormonal-Imbalance Treatment
08/24/201619:20:00FDA Rejects Amgen Hormonal-Imbalance Treatment
08/24/201618:03:00Amgen Provides Update On Status Of Parsabiv™ (Etelcalcetide) N...
08/22/201609:00:00New Data Add To Understanding Of Repatha® (Evolocumab) In Multiple...
08/22/201608:50:00Eli Lilly, AstraZeneca Progress With Alzheimer's Drug
08/19/201616:14:16Current Report Filing (8-k)
08/11/201617:29:34Prospectus Filed Pursuant to Rule 424(b)(2) (424b2)
08/11/201606:06:00Free Writing Prospectus - Filing Under Securities Act Rules 163/433...
08/10/201608:27:19Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)
08/06/201603:03:00AbbVie Sues Amgen Over Humira -- WSJ
08/05/201616:57:00AbbVie Files Patent Suit Over Amgen's Copy of Humira -- Update
08/05/201614:50:00AbbVie Sues Amgen Over Humira
08/05/201614:33:00AbbVie Files Patent Suit Over Amgen's Copy of Humira
08/02/201619:30:00CVS Drops Coverage of 2 Branded Biotech Drugs in Favor of Copies
08/02/201618:47:00CVS Drops Coverage of 2 Branded Biotech Drugs in Favor of Copies
08/02/201610:28:00Advaxis Shares Higher on Collaboration Deal With Amgen
08/02/201608:00:00Amgen And Advaxis Enter Global Cancer Immunotherapies Collaboration
07/29/201616:50:00Quarterly Report (10-q)
07/28/201609:42:00U.S. Hot Stocks: Hot Stocks to Watch

Amgen Inc. and other NASDAQ stock quotes are delayed by at least 20 minutes.
All other stock price and quote data is delayed by at least 15 minutes unless otherwise stated. By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Contact Us | Copyright 1999-2015 ADVFN PLC. | Privacy Policy | Investment Warning | Data accreditations | Investor Relations

ADVFNADVFN ItalyADVFN GermanyADVFN FranceADVFN BrazilADVFN JapanADVFN UKADVFN US noad